Consumer protection: unfair trade practices; insulin drug pricing report; require by the department of attorney general. Amends 1976 PA 331 (MCL 445.901 - 445.922) by adding sec. 9b.
Key claim: HB6132 would amend Michigan’s Consumer Protection Act to require the Department of Attorney General to produce a report on insulin drug pricing.
Abstract
(HB6132 · 103rd Legislature) Consumer protection: unfair trade practices; insulin drug pricing report; require by the department of attorney general. Amends 1976 PA 331 (MCL 445.901 - 445.922) by adding sec. 9b. Latest action (2026-06-30): Bill Electronically Reproduced 06/25/2026
Why this matters
For Michigan consumers, insulin costs are a recurring affordability concern, and directing the Attorney General to report on pricing puts the state’s consumer-protection apparatus on record about the market. The bill signals continued legislative interest in using the 1976 Consumer Protection Act as a vehicle for drug-pricing oversight, though a report requirement alone does not change what manufacturers, pharmacies, or insurers may charge.